
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. has experienced a positive financial outlook, with normalized funds from operations (NFFO) estimates for 2025 rising to $4.80 per share, slightly above the adjusted guidance range of $4.78 to $4.82 per share from management. The company's performance reflects a robust year-over-year growth forecast, projecting a 5.3% increase in normalized FFO per share in 2025 and an additional 4.8% growth anticipated for 2026. Additionally, the upward revision of the 2026 FFO estimate to $5.03 per share, exceeding consensus expectations, further reinforces the company's strong financial trajectory.
Bears say
National Health Investors Inc faces a negative outlook primarily due to the anticipated lower earnings growth over the next few years, which reflects a challenge in balancing accretive acquisition activity with potential operational disruptions. The company's performance could be adversely affected by a lower-than-expected rent reset from National HealthCare Corporation, as well as risks associated with deferred rent collections and operator challenges, which may be exacerbated by ongoing public health concerns. These factors contribute to a cautious view on the company’s financial stability and revenue projections.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares